About the Infographic
  • Early clinical highlights, including preliminary results for the PARP1-selective AZD5305 and the ATRi RP-3500.
  • A review of emerging preclinical and clinical WEE1i data, including a look at developers investigating WEE1.
  • A brief look at the future of synthetic lethality.

Find out more

 

This insight and data is part of the subscription to Beacon DDR.

Beacon DDR Logo

 

Find out more

Speak with our Team

Our dedicated Sales and Research teams can help you with questions by showing you how this insight and data is collated on Beacon

Frank Plowden  

 

Request a Demo

About Beacon Targeted Therapies

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.

 

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

logo
Verified by MonsterInsights